| Dr Michael John Miller, MD | |
|
3637 Cape Center Dr, Fayetteville, NC 28304-4457 | |
| (910) 491-1760 | |
| (910) 491-1764 |
| Full Name | Dr Michael John Miller |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 39 Years |
| Location | 3637 Cape Center Dr, Fayetteville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194719559 | NPI | - | NPPES |
| 59111 | Other | NC | BCBS NC |
| 8959111 | Medicaid | NC | |
| 60045022 | Other | NC | RAILROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Haywood Regional Medical Center | Clyde, NC | Hospital |
| Harris Regional Hospital | Sylva, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dlp Western Carolina Physician Practices Llc | 9032338975 | 112 |
| Dlp Haywood Regional Medical Center Llc | 9638398340 | 21 |
News Archive
Congressional Democrats are scurrying today to advance a $192 billion catch-all legislative package that includes "safety-net benefits for the unemployed, physician reimbursements, tax breaks for businesses and other provisions."
Four percent of Canadians aged 12 to 14 years old had consumed five or more drinks on at least one occasion in the preceding year, according to a new study from the University of Toronto. The study was published this week in the journal ISRN Public Health.
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
Trace amounts of flame retardants, banned in the U.S. for more than a decade, are still being passed through umbilical cord blood from mothers to their babies, according to new Indiana University research.
Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
› Verified 2 days ago
| Entity Name | The Presbyterian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053365817 PECOS PAC ID: 1153231907 Enrollment ID: O20040223001121 |
News Archive
Congressional Democrats are scurrying today to advance a $192 billion catch-all legislative package that includes "safety-net benefits for the unemployed, physician reimbursements, tax breaks for businesses and other provisions."
Four percent of Canadians aged 12 to 14 years old had consumed five or more drinks on at least one occasion in the preceding year, according to a new study from the University of Toronto. The study was published this week in the journal ISRN Public Health.
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
Trace amounts of flame retardants, banned in the U.S. for more than a decade, are still being passed through umbilical cord blood from mothers to their babies, according to new Indiana University research.
Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
› Verified 2 days ago
| Entity Name | Novant Health Rowan Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508931544 PECOS PAC ID: 3375452519 Enrollment ID: O20040422001655 |
News Archive
Congressional Democrats are scurrying today to advance a $192 billion catch-all legislative package that includes "safety-net benefits for the unemployed, physician reimbursements, tax breaks for businesses and other provisions."
Four percent of Canadians aged 12 to 14 years old had consumed five or more drinks on at least one occasion in the preceding year, according to a new study from the University of Toronto. The study was published this week in the journal ISRN Public Health.
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
Trace amounts of flame retardants, banned in the U.S. for more than a decade, are still being passed through umbilical cord blood from mothers to their babies, according to new Indiana University research.
Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
› Verified 2 days ago
| Entity Name | Novant Health Matthews Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184782419 PECOS PAC ID: 6406845247 Enrollment ID: O20051114000445 |
News Archive
Congressional Democrats are scurrying today to advance a $192 billion catch-all legislative package that includes "safety-net benefits for the unemployed, physician reimbursements, tax breaks for businesses and other provisions."
Four percent of Canadians aged 12 to 14 years old had consumed five or more drinks on at least one occasion in the preceding year, according to a new study from the University of Toronto. The study was published this week in the journal ISRN Public Health.
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
Trace amounts of flame retardants, banned in the U.S. for more than a decade, are still being passed through umbilical cord blood from mothers to their babies, according to new Indiana University research.
Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
› Verified 2 days ago
| Entity Name | Carolina Heart And Leg Center, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124450572 PECOS PAC ID: 2466689641 Enrollment ID: O20131213000894 |
News Archive
Congressional Democrats are scurrying today to advance a $192 billion catch-all legislative package that includes "safety-net benefits for the unemployed, physician reimbursements, tax breaks for businesses and other provisions."
Four percent of Canadians aged 12 to 14 years old had consumed five or more drinks on at least one occasion in the preceding year, according to a new study from the University of Toronto. The study was published this week in the journal ISRN Public Health.
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
Trace amounts of flame retardants, banned in the U.S. for more than a decade, are still being passed through umbilical cord blood from mothers to their babies, according to new Indiana University research.
Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
› Verified 2 days ago
| Entity Name | Dlp Western Carolina Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609281641 PECOS PAC ID: 9032338975 Enrollment ID: O20140908002531 |
News Archive
Congressional Democrats are scurrying today to advance a $192 billion catch-all legislative package that includes "safety-net benefits for the unemployed, physician reimbursements, tax breaks for businesses and other provisions."
Four percent of Canadians aged 12 to 14 years old had consumed five or more drinks on at least one occasion in the preceding year, according to a new study from the University of Toronto. The study was published this week in the journal ISRN Public Health.
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
Trace amounts of flame retardants, banned in the U.S. for more than a decade, are still being passed through umbilical cord blood from mothers to their babies, according to new Indiana University research.
Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
› Verified 2 days ago
| Entity Name | Dlp Haywood Regional Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336542067 PECOS PAC ID: 9638398340 Enrollment ID: O20150109001818 |
News Archive
Congressional Democrats are scurrying today to advance a $192 billion catch-all legislative package that includes "safety-net benefits for the unemployed, physician reimbursements, tax breaks for businesses and other provisions."
Four percent of Canadians aged 12 to 14 years old had consumed five or more drinks on at least one occasion in the preceding year, according to a new study from the University of Toronto. The study was published this week in the journal ISRN Public Health.
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
Trace amounts of flame retardants, banned in the U.S. for more than a decade, are still being passed through umbilical cord blood from mothers to their babies, according to new Indiana University research.
Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
› Verified 2 days ago
| Entity Name | Legacy Heart Care Of Charlotte, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467810663 PECOS PAC ID: 7113225814 Enrollment ID: O20160413001274 |
News Archive
Congressional Democrats are scurrying today to advance a $192 billion catch-all legislative package that includes "safety-net benefits for the unemployed, physician reimbursements, tax breaks for businesses and other provisions."
Four percent of Canadians aged 12 to 14 years old had consumed five or more drinks on at least one occasion in the preceding year, according to a new study from the University of Toronto. The study was published this week in the journal ISRN Public Health.
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
Trace amounts of flame retardants, banned in the U.S. for more than a decade, are still being passed through umbilical cord blood from mothers to their babies, according to new Indiana University research.
Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael John Miller, MD 3637 Cape Center Dr, Fayetteville, NC 28304-4457 Ph: (910) 491-1760 | Dr Michael John Miller, MD 3637 Cape Center Dr, Fayetteville, NC 28304-4457 Ph: (910) 491-1760 |
News Archive
Congressional Democrats are scurrying today to advance a $192 billion catch-all legislative package that includes "safety-net benefits for the unemployed, physician reimbursements, tax breaks for businesses and other provisions."
Four percent of Canadians aged 12 to 14 years old had consumed five or more drinks on at least one occasion in the preceding year, according to a new study from the University of Toronto. The study was published this week in the journal ISRN Public Health.
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
Trace amounts of flame retardants, banned in the U.S. for more than a decade, are still being passed through umbilical cord blood from mothers to their babies, according to new Indiana University research.
Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
› Verified 2 days ago
Kenneth Melton, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 557 Sandhurst Dr, Fayetteville, NC 28304 Phone: 910-484-8114 Fax: 910-484-1564 | |
Kenneth Russell Manning, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-609-6910 Fax: 910-609-5219 | |
San San Wai, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2300 Ramsey St, Va Medical Center, Fayetteville, NC 28301 Phone: 910-488-2120 | |
Dr. Sabena Johnson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Ramsey St, Fayetteville, NC 28301 Phone: 910-488-2120 | |
Dr. Stephen S Logue, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1843 Quiet Cv, Fayetteville, NC 28304 Phone: 910-483-8080 Fax: 910-483-3258 | |
David Tat, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Owen Dr, Fayetteville, NC 28304 Phone: 910-678-0100 Fax: 910-678-0110 | |
Dr. Ghanshyam Pradyumna Dwivedi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1778 Metromedical Dr, Fayetteville, NC 28304 Phone: 910-483-4680 Fax: 910-484-2704 |